Chandrakanth Are

Dr. Chandrakanth Are is a surgical oncologist at the Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, specializing in gastrointestinal malignancies. His clinical expertise encompasses liver, pancreatic, colorectal, gallbladder, and stomach cancer surgery, including advanced techniques like fluorescence-guided resection.

Educational background includes:

• MBBS: Osmania Medical College (1988)
• Internship: Osmania General Hospital (1989)
• Fellowship in General Surgery: Our Lady's Hospital/Beaumont Hospital (1996)
• Residency in General Surgery: Johns Hopkins Hospital (2003)
• Fellowship in Gastroenterology: Johns Hopkins Hospital (2004)
• Fellowship in Surgical Oncology: Memorial Sloan-Kettering Cancer Center (2006)

His research focuses on refining surgical approaches for hepatobiliary and gastrointestinal cancers, developing clinical guidelines through NCCN, and investigating molecular pathways like PI3K/Akt/mTOR for targeted therapies. Dr. Are maintains active contributions to oncological literature with 196+ publications emphasizing evidence-based surgical management and emerging treatment paradigms.

Dr. Are has contributed to establishing standardized care protocols through his work on national guidelines for biliary tract and hepatobiliary cancers. His recent publications demonstrate sustained academic productivity with articles addressing evolving strategies in metastatic colorectal cancer management and intraoperative technologies.